Cardiology News and Research

Latest Cardiology News and Research

Stem cell therapy to treat heart, lung and vascular diseases show positive results

A Florida cardiologist is using stem cell therapy to treat patients who suffer from a range of heart, lung and vascular illnesses. The results have been extraordinary.

16 Nov 2009

Additional data from Aegerion Pharmaceuticals' ongoing lomitapide Phase III trial

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of cardiovascular and metabolic disease, today announced additional data from its ongoing Phase III trial involving its lead cholesterol management compound, lomitapide (AEGR-733), which is a microsomal triglyceride transfer protein (MTP) inhibitor small molecule drug.

16 Nov 2009

Migraine headaches linked with increased risk of common kind of stroke

Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with more than twofold higher chances of the most common kind of stroke: those occurring when blood supply to the brain is suddenly cut off by the buildup of plaque or a blood clot.

16 Nov 2009

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Sciele Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd. and Addrenex Pharmaceuticals, Inc., a privately-held U.S. pharmaceutical company specializing in developing drugs that regulate the adrenergic system, today announced that Sciele has agreed to acquire Addrenex.

16 Nov 2009

Coming this week: New law to prevent discrimination based on genes

"The most important new antidiscrimination law in two decades — the Genetic Information Nondiscrimination Act — will take effect in the nation's workplaces next weekend, prohibiting employers from requesting genetic testing or considering someone's genetic background in hiring, firing or promotions," The New York Times reports.

16 Nov 2009

Color of skin impacts health, say researchers

Researchers from the universities of Bristol and St. Andrews in the UK have found that the color of a person's skin affects how healthy and therefore attractive they appear, and have found that diet may be crucial to achieving the most desirable complexion. The work will be published in the December issue of Springer's International Journal of Primatology.

16 Nov 2009

China Medicine reports total revenues of $19.2M for the third quarter of 2009

China Medicine Corporation, a developer and a leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations, today announced its third quarter 2009 results.

16 Nov 2009

Cambridge Heart announces financial results for the third quarter of 2009

Cambridge Heart, Inc., today reported results for its third quarter ended September 30, 2009. The following financial and strategic items highlight the Company’s activity for the third quarter.

16 Nov 2009

FDA approves Lysteda for treating menorrhagia

Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral tablets has received U.S. Food and Drug Administration (FDA) approval for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.

16 Nov 2009

Genetic test for familial Dilated Cardiomyopathy launched by PGxHealth

PGxHealth, a division of Clinical Data, Inc., today announced the launch of its genetic test for familial Dilated Cardiomyopathy, an inherited heart disease which is the leading cause of heart transplants and a possible cause of sudden cardiac death.

16 Nov 2009

Platelet function tests predict heart attacks in patients pre-treated with two anti-clotting medications before coronary stenting

Three platelet function tests all identified heart patients who will have blood cells that remain sticky, increasing heart attack risk, despite being pre-treated with two anti-clotting medications before coronary stenting, researchers reported at the American Heart Association's Scientific Sessions 2009.

16 Nov 2009

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Fewer than one-third of patients with heart failure are taking the three types of medications that are most effective in prolonging life and improving quality of life. The November issue of Mayo Clinic Health Letter provides an overview of treatments recommended by national guidelines.

16 Nov 2009

Sunlight Saunas renamed as Sunlighten

After a thorough, long-term strategic brand-building process, Sunlighten(TM) has been chosen as the new name for health & wellness leader Sunlight Saunas(TM). Under the same ownership and with a renewed sense of corporate mission, Sunlighten has plans for a host of cutting-edge wellness products over the coming years, including advances in its line of long-celebrated infrared saunas.

16 Nov 2009

Self-care tips for hemorrhoids from Mayo Clinic

By about age 50, more than half of adults have dealt with hemorrhoids. The November issue of Mayo Clinic Health Letter covers home treatments that can relieve symptoms of this common and embarrassing problem.

16 Nov 2009

Tips to ensure adequate vitamin D levels

Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus.

16 Nov 2009

Postmortem genetic testing to identify genetic mutations after SUD effective in identifying risk

Targeted postmortem testing to identify genetic mutations associated with sudden unexplained death (SUD) is an effective and less expensive way to determine risk to relatives than comprehensive cardiac testing of first degree relatives, according to research presented at the American Heart Association's Scientific Sessions 2009.

16 Nov 2009

Transcendental Meditation lowers rates of heart attack, stroke, and death

Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009.

16 Nov 2009

New faces of HIV/AIDS: A report

World AIDS Day 2009 will be marked with both grim and hopeful data: more than 25 million people have died of AIDS worldwide since 1981; 33 million are living with HIV/AIDS. While potent, effective medications have changed an HIV diagnosis from death sentence to manageable chronic illness in resource rich countries, global rates of infection still outstrip prevention and treatment capacity.

16 Nov 2009

HealthPartners' health plans ranked top in Minnesota

HealthPartners is among the top 25 best private health plans in the nation and the top ranked plan in Minnesota according to U.S. News & World Report/NCQA “America's Best Health Insurance Plans 2009-10.” The report measures how well health plans perform on 50 measures of health care and member satisfaction. Two hundred thirty nine health plans from across the nation are included in the report. The top 50 health plans, including HealthPartners, are listed in the Nov. 16, 2009 print edition of U.S. News & World Report.

16 Nov 2009

RecordAF presents results of recently diagnosed and treated patients with atrial fibrillation

Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively treated patients with atrial fibrillation (AF), a rhythm-control strategy provides better short term control of the arrhythmia versus a rate-control strategy but does not translate into a reduction in the occurrence of clinical events at 1 year.

16 Nov 2009

Cardiology News and Research

Latest Cardiology News and Research

Stem cell therapy to treat heart, lung and vascular diseases show positive results

Additional data from Aegerion Pharmaceuticals' ongoing lomitapide Phase III trial

Migraine headaches linked with increased risk of common kind of stroke

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Coming this week: New law to prevent discrimination based on genes

Color of skin impacts health, say researchers

China Medicine reports total revenues of $19.2M for the third quarter of 2009

Cambridge Heart announces financial results for the third quarter of 2009

FDA approves Lysteda for treating menorrhagia

Genetic test for familial Dilated Cardiomyopathy launched by PGxHealth

Platelet function tests predict heart attacks in patients pre-treated with two anti-clotting medications before coronary stenting

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Sunlight Saunas renamed as Sunlighten

Self-care tips for hemorrhoids from Mayo Clinic

Tips to ensure adequate vitamin D levels

Postmortem genetic testing to identify genetic mutations after SUD effective in identifying risk

Transcendental Meditation lowers rates of heart attack, stroke, and death

New faces of HIV/AIDS: A report

HealthPartners' health plans ranked top in Minnesota

RecordAF presents results of recently diagnosed and treated patients with atrial fibrillation

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Cardiology News and Research

Latest Cardiology News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in